MedPath
NMPA Product

Ranitidine Hydroride Capsules

Product approved by National Medical Products Administration (CN)

Basic Information

Ranitidine Hydroride Capsules

盐酸雷尼替丁胶囊

0.15g

胶囊剂

Regulatory Information

国药准字H50021259

Approved

化学药品

April 8, 2020

Company Information

Active Ingredients

© Copyright 2025. All Rights Reserved by MedPath